TY - JOUR
T1 - Measuring atopic eczema symptoms in clinical practice
T2 - The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
AU - Harmonising Outcome Measures for Eczema (HOME) initiative
AU - Leshem, Yael A.
AU - Chalmers, Joanne R.
AU - Apfelbacher, Christian
AU - Furue, Masutaka
AU - Gerbens, Louise A.A.
AU - Prinsen, Cecilia A.C.
AU - Schmitt, Jochen
AU - Spuls, Phyllis I.
AU - Thomas, Kim S.
AU - Williams, Hywel C.
AU - Simpson, Eric L.
N1 - Publisher Copyright:
© 2020 American Academy of Dermatology, Inc.
PY - 2020/5
Y1 - 2020/5
N2 - Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to recommend what might be recorded for atopic eczema patients in routine clinical care. Objectives: Prioritize outcome domains to measure atopic eczema in clinical practice and select valid and practical outcome measurement instruments for the highest-priority domain. Methods: An online survey of HOME members identified and ranked 21 possible health domains. Suitable instruments were then selected for the top-prioritized domain at the HOME VI meeting, using established consensus processes informed by systematic reviews of instrument quality. Results: Patient-reported symptoms was the top-prioritized domain. In accordance with psychometric properties and feasibility, there was consensus that the recommended instruments to measure atopic eczema symptoms in clinical practice are the POEM, the PO-SCORAD index, or both. The numeric rating scale for itch received support pending definition and validation in atopic eczema. Conclusion: Following the first step of the HOME Clinical Practice initiative, we endorse using the POEM, the PO-SCORAD index, or both for measuring atopic eczema symptoms in clinical practice. Additional high-priority domains for clinical practice will be assessed at subsequent HOME meetings.
AB - Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to recommend what might be recorded for atopic eczema patients in routine clinical care. Objectives: Prioritize outcome domains to measure atopic eczema in clinical practice and select valid and practical outcome measurement instruments for the highest-priority domain. Methods: An online survey of HOME members identified and ranked 21 possible health domains. Suitable instruments were then selected for the top-prioritized domain at the HOME VI meeting, using established consensus processes informed by systematic reviews of instrument quality. Results: Patient-reported symptoms was the top-prioritized domain. In accordance with psychometric properties and feasibility, there was consensus that the recommended instruments to measure atopic eczema symptoms in clinical practice are the POEM, the PO-SCORAD index, or both. The numeric rating scale for itch received support pending definition and validation in atopic eczema. Conclusion: Following the first step of the HOME Clinical Practice initiative, we endorse using the POEM, the PO-SCORAD index, or both for measuring atopic eczema symptoms in clinical practice. Additional high-priority domains for clinical practice will be assessed at subsequent HOME meetings.
UR - http://www.scopus.com/inward/record.url?scp=85079884956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079884956&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2019.12.055
DO - 10.1016/j.jaad.2019.12.055
M3 - Article
C2 - 31926221
AN - SCOPUS:85079884956
SN - 0190-9622
VL - 82
SP - 1181
EP - 1186
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 5
ER -